Dr. Reddy's [DRREDDY] vs Lupin [LUPIN] Detailed Stock Comparison
Dr. Reddy's
NSE
Loading...
Lupin
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Dr. Reddy's wins in 10 metrics, Lupin wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Dr. Reddy's | Lupin | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 17.96 | 24.21 | Dr. Reddy's |
| Price-to-Book Ratio | 2.91 | 5.18 | Dr. Reddy's |
| Debt-to-Equity Ratio | 13.75 | 31.50 | Dr. Reddy's |
| PEG Ratio | 3.57 | 23.90 | Dr. Reddy's |
| EV/EBITDA | 11.20 | 16.90 | Dr. Reddy's |
| Profit Margin (TTM) | 16.99% | 15.83% | Dr. Reddy's |
| Operating Margin (TTM) | 20.50% | 23.23% | Lupin |
| EBITDA Margin (TTM) | 20.50% | 23.23% | Lupin |
| Return on Equity | 17.71% | 18.98% | Lupin |
| Return on Assets (TTM) | 9.71% | 11.24% | Lupin |
| Free Cash Flow (TTM) | $12.03B | $13.18B | Lupin |
| Dividend Yield | 11.59% | 0.62% | Dr. Reddy's |
| 1-Year Return | -7.24% | -5.97% | Lupin |
| Price-to-Sales Ratio (TTM) | 3.05 | 3.82 | Dr. Reddy's |
| Enterprise Value | $1,001.39B | $912.96B | Dr. Reddy's |
| EV/Revenue Ratio | 3.00 | 3.91 | Dr. Reddy's |
| Gross Profit Margin (TTM) | 56.91% | 71.25% | Lupin |
| Revenue per Share (TTM) | $401 | $512 | Lupin |
| Earnings per Share (Diluted) | $68.17 | $80.71 | Lupin |
| Beta (Stock Volatility) | 0.31 | 0.30 | Lupin |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Dr. Reddy's vs Lupin Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dr. Reddy's | 0.56% | 4.96% | 0.78% | 3.31% | 5.29% | -7.93% |
| Lupin | -1.42% | 0.89% | 1.84% | -5.30% | -0.42% | -17.05% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dr. Reddy's | -7.24% | 49.90% | 40.36% | 48.49% | 375.21% | 1,436.32% |
| Lupin | -5.97% | 184.72% | 99.88% | 4.46% | 428.78% | 2,413.58% |
Performance & Financial Health Analysis: Dr. Reddy's vs Lupin
| Metric | DRREDDY | LUPIN |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.02T | ₹892.97B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,372,800 | 1,391,504 |
| 90 Day Avg. Volume | 1,382,405 | 1,114,408 |
| Last Close | ₹1,260.40 | ₹1,961.60 |
| 52 Week Range | ₹1,020.00 - ₹1,421.49 | ₹1,795.20 - ₹2,402.90 |
| % from 52W High | -11.33% | -18.37% |
| All-Time High | ₹1,421.49 (Aug 19, 2024) | ₹2,402.90 (Dec 30, 2024) |
| % from All-Time High | -11.33% | -18.37% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.12% |
| Quarterly Earnings Growth | 0.02% | 0.52% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.16% |
| Operating Margin (TTM) | 0.21% | 0.23% |
| Return on Equity (TTM) | 0.18% | 0.19% |
| Debt to Equity (MRQ) | 13.75 | 31.50 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹420.56 | ₹376.80 |
| Cash per Share (MRQ) | ₹80.12 | ₹65.49 |
| Operating Cash Flow (TTM) | ₹52.56B | ₹28.04B |
| Levered Free Cash Flow (TTM) | ₹14.23B | ₹32.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | 11.59% | 0.62% |
| Last 12-Month Dividend | ₹146.30 | ₹12.00 |
Valuation & Enterprise Metrics Analysis: Dr. Reddy's vs Lupin
| Metric | DRREDDY | LUPIN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 17.96 | 24.21 |
| Forward P/E | 3.57 | 23.90 |
| PEG Ratio | 3.57 | 23.90 |
| Price to Sales (TTM) | 3.05 | 3.82 |
| Price to Book (MRQ) | 2.91 | 5.18 |
| Market Capitalization | ||
| Market Capitalization | ₹1.02T | ₹892.97B |
| Enterprise Value | ₹1.00T | ₹912.96B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.00 | 3.91 |
| Enterprise to EBITDA | 11.20 | 16.90 |
| Risk & Other Metrics | ||
| Beta | 0.31 | 0.30 |
| Book Value per Share (MRQ) | ₹420.56 | ₹376.80 |
Financial Statements Comparison: Dr. Reddy's vs Lupin
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DRREDDY | LUPIN |
|---|---|---|
| Revenue/Sales | ₹85.45B | ₹61.64B |
| Cost of Goods Sold | ₹36.83B | ₹17.72B |
| Gross Profit | ₹48.63B | ₹43.92B |
| Research & Development | ₹6.24B | N/A |
| Operating Income (EBIT) | ₹16.84B | ₹32.28B |
| EBITDA | ₹23.41B | ₹18.81B |
| Pre-Tax Income | ₹19.05B | ₹14.16B |
| Income Tax | ₹4.95B | ₹1.94B |
| Net Income (Profit) | ₹14.10B | ₹12.21B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DRREDDY | LUPIN |
|---|---|---|
| Cash & Equivalents | ₹14.65B | ₹19.31B |
| Total Current Assets | ₹250.11B | ₹167.99B |
| Total Current Liabilities | ₹130.39B | ₹89.61B |
| Long-Term Debt | ₹7.86B | ₹20.31B |
| Total Shareholders Equity | ₹337.17B | ₹172.94B |
| Retained Earnings | ₹315.79B | ₹140.71B |
| Property, Plant & Equipment | ₹0 | ₹84.20M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DRREDDY | LUPIN |
|---|---|---|
| Operating Cash Flow | ₹27.79B | N/A |
| Capital Expenditures | ₹-7.67B | N/A |
| Free Cash Flow | ₹10.75B | N/A |
| Debt Repayment | ₹-253.00M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DRREDDY | LUPIN |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,372,800 | 1,391,504 |
| Average Daily Volume (90 Day) | 1,382,405 | 1,114,408 |
| Shares Outstanding | 832.00M | 456.57M |
| Float Shares | 595.10M | 241.62M |
| % Held by Insiders | 0.29% | 0.47% |
| % Held by Institutions | 0.50% | 0.37% |
Dividend Analysis & Yield Comparison: Dr. Reddy's vs Lupin
| Metric | DRREDDY | LUPIN |
|---|---|---|
| Last 12-Month Dividend | ₹146.30 | ₹12.00 |
| Last 12-Month Dividend Yield | 11.59% | 0.62% |
| 3-Year Avg Annual Dividend | ₹49.30 | ₹8.00 |
| 3-Year Avg Dividend Yield | 3.74% | 0.50% |
| 3-Year Total Dividends | ₹147.90 | ₹24.00 |
| Ex-Dividend Date | Jul 10, 2025 | Jul 25, 2025 |